mesalazine 1.2 takeda (mesalazine) 1.2 g prolonged release tablet blister pack
takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.
mesalazine teva 500 mg compr. gastro-résist.
teva pharma belgium sa-nv - mésalazine 500 mg - comprimé gastro-résistant - 500 mg - mésalazine 500 mg - mesalazine
mesalazine teva 500 mg maagsapresist. tabl.
teva pharma belgium sa-nv - mesalazine 500 mg - maagsapresistente tablet - 500 mg - mesalazine 500 mg - mesalazine
mesalazine i.p.s 250 mg compr. gastro-résist.
international pharmaceutical services sa-nv - mésalazine 250 mg - comprimé gastro-résistant - 250 mg - mésalazine 250 mg - mesalazine
mesalazine i.p.s 500 mg compr. gastro-résist.
international pharmaceutical services sa-nv - mésalazine 500 mg - comprimé gastro-résistant - 500 mg - mésalazine 500 mg - mesalazine
mesalazine i.p.s 250 mg maagsapresist. tabl.
international pharmaceutical services sa-nv - mesalazine 250 mg - maagsapresistente tablet - 250 mg - mesalazine 250 mg - mesalazine
mesalazine i.p.s 500 mg maagsapresist. tabl.
international pharmaceutical services sa-nv - mesalazine 500 mg - maagsapresistente tablet - 500 mg - mesalazine 500 mg - mesalazine
mesalazine/espl 1600mg/tab δισκιο ελεγχομενησ αποδεσμευσησ
espl regulatory consulting limited, ireland (0000012517) unit 3d north point house,, cork, - - mesalazine - ΔΙΣΚΙΟ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ - 1600mg/tab - 0000089576 mesalazine 1600.000000 mg - mesalazine
mesalazine aurobindo ec 250 mg, maagsapresistente tabletten
aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - mesalazine 250 mg/stuk - maagsapresistente tablet - cellulose, microkristallijn (e 460) ; copolymeer van methacrylzuur-methylmethacrylaat (1:2) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; crospovidon (e 1202) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; povidon (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505), - mesalazine
mesalazine aurobindo ec 500 mg, maagsapresistente tabletten
aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - mesalazine 500 mg/stuk - maagsapresistente tablet - cellulose, microkristallijn (e 460) ; copolymeer van methacrylzuur-methylmethacrylaat (1:2) ; copolymeer van methacrylzuur-methylmethacrylaat (1:1) ; crospovidon (e 1202) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; magnesiumstearaat (e 470b) ; polyethyleenglycol (e 1521) ; povidon (e 1201) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505), - mesalazine